Artificial Intelligence

Stamford Health Launches Pilot Integrating ECG-Based AI for Structural Heart Screening

Advertisement
Advertise on GlobeWire Daily

· GlobeWire Daily Editorial Desk · Source: www.prnewswire.com

2 min read

Key takeawaysA new clinical pilot has been launched at Stamford Health in Connecticut to evaluate an artificial intelligence tool designed to screen for structural heart disease and other cardiac conditions using routine electrocardiograms (ECGs).
Stamford Health Launches Pilot Integrating ECG-Based AI for Structural Heart Screening

Original GlobeWire Daily editorial illustration — not an event photograph.

A new clinical pilot has been launched at Stamford Health in Connecticut to evaluate an artificial intelligence tool designed to screen for structural heart disease and other cardiac conditions using routine electrocardiograms (ECGs).

Project Overview

The initiative brings together healthcare technology company egnite, Pathway Labs, and Stamford Health. It integrates Pathway Labs' recently cleared AI algorithm, known as EchoNext, directly into egnite's CardioCare platform.

  • Technology Purpose: EchoNext analyzes 12-lead ECG waveforms to identify signals associated with structural heart conditions, heart failure, and pulmonary hypertension from a single screening.
  • Workflow Integration: The CardioCare platform reviews the AI findings alongside the patient's longitudinal electronic health record (EHR) data, including prior history and lab results.
  • Objective: To surface pre-qualified patients who may benefit from echocardiographic follow-up and to measure downstream clinical impacts, such as echo completion rates and time to specialist evaluation.

Practical Implications and Implementation

Clinical leaders involved in the project note that while automated screening can identify potential risks, the primary challenge remains ensuring that flagged patients receive timely follow-up without placing an undue burden on clinical staff. By incorporating multiple screening inputs into existing workflows, the CardioCare platform aims to bridge the gap between initial detection and diagnosis.

Funding for the pilot is being supported by Edwards Lifesciences as part of a collaborative effort to promote earlier identification of structural heart conditions.

How to Verify

  • Review official press releases and institutional announcements published by Stamford Health, egnite, and Pathway Labs.
  • Consult regulatory disclosures regarding the U.S. Food and Drug Administration (FDA) clearance status of the EchoNext algorithm.
  • Access published organizational literature through official websites such as StamfordHealth.org and egnitehealth.com.
Share this article
Read the original source: egnite, Pathway Labs and Stamford Health Launch First-of-Its-Kind Pilot Using ECG-Based AI to Help Clinicians Identify and Manage Structural Heart Patients

AI-assisted reporting; source claims are attributed and have not been independently verified.

About the author

GlobeWire Daily Editorial Desk — AI-assisted news based on attributed published sources.

More to read